Objectives: Metformin is the most widely preferred first-line oral antidiabetic agent that results in clear benefits in blood sugar regulation and diabetes-related complications. This study is aimed at assessing the effect of metformin on anthropometric, hormonal, and biochemical parameters in patients with prediabetes or insulin resistance.
Methods: A prepoststudy was conducted among 52 patients with prediabetes or insulin resistance who met the inclusion criteria.